Genovese Burford & Brothers Wealth & Retirement Plan Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Genovese Burford & Brothers Wealth & Retirement Plan Management's BMY Position: Q4 2020 in Review
Genovese Burford & Brothers Wealth & Retirement Plan Management reduced its Bristol-Myers Squibb (BMY) stake by 4% in Q4 2020, selling an estimated $11.7K and leaving 4,509 shares worth $280K. The position accounts for 0.07% of the portfolio, ranked #92.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in BMY in Q4 2015 and has held it in 20 quarters since. The position peaked at $349K in Q1 2018. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.
- Genovese Burford & Brothers Wealth & Retirement Plan Management held 4,509 shares of Bristol-Myers Squibb worth $280K as of Q4 2020.
- Genovese Burford & Brothers Wealth & Retirement Plan Management sold 190 Bristol-Myers Squibb shares in Q4 2020, an estimated $11.7K.
- Bristol-Myers Squibb made up 0.07% of Genovese Burford & Brothers Wealth & Retirement Plan Management's portfolio in Q4 2020, its #92 holding.
- Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 20 quarters since.
- Genovese Burford & Brothers Wealth & Retirement Plan Management's Bristol-Myers Squibb position peaked at $349K in Q1 2018.
- 2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.
Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q4 2020, filed 5 Feb 2021.